Interim Results of Expanded Access for Deltarex-G for an Intermediate Size Population with Advanced Pancreatic Cancer and Sarcoma (NCT04091295) and Single Patient Use INDS for Early Stage Triple Receptor Positive, and Triple Receptor Negative Breast Cancer (IND# 19130)
MOLECULAR THERAPY(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要